Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · IEX Real-Time Price · USD
0.400
-0.010 (-2.44%)
At close: May 26, 2022 4:00 PM
0.395
-0.005 (-1.250%)
After-hours:May 26, 2022 7:33 PM EDT
Balance Sheet (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.63 | 7.64 | 5.34 | 10.66 | 11.95 | 20.8 | 3.83 |
| Short-Term Investments | 42.33 | 6.76 | 12.97 | 10.06 | 38.89 | 0 | 0 |
| Cash & Cash Equivalents | 45.96 | 14.4 | 18.3 | 20.72 | 50.84 | 20.8 | 3.83 |
| Cash Growth | 219.20% | -21.34% | -11.67% | -59.24% | 144.39% | 443.02% | - |
| Other Current Assets | 2.22 | 1.93 | 1.25 | 1.06 | 1 | 0.27 | 0.2 |
| Total Current Assets | 48.18 | 16.33 | 19.55 | 21.78 | 51.84 | 21.07 | 4.03 |
| Property, Plant & Equipment | 0.28 | 0.02 | 6.36 | 7.29 | 0.15 | 0.11 | 0.35 |
| Long-Term Investments | 0 | 0 | 0.57 | 0.57 | 0 | 0 | 0 |
| Other Long-Term Assets | 0.02 | 0 | 0 | 0.68 | 0.69 | 0.84 | 1.56 |
| Total Long-Term Assets | 0.3 | 0.02 | 6.92 | 8.54 | 0.85 | 0.95 | 1.91 |
| Total Assets | 48.48 | 16.34 | 26.47 | 30.31 | 52.69 | 22.02 | 5.94 |
| Accounts Payable | 1.21 | 1.6 | 1.45 | 1.73 | 1.6 | 1.97 | 0.64 |
| Current Debt | 0.09 | 0.17 | 0.45 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.21 | 2.2 | 3.94 | 3.64 | 3.29 | 2.1 | 1.91 |
| Total Current Liabilities | 4.51 | 3.96 | 5.84 | 5.37 | 4.89 | 4.07 | 2.55 |
| Long-Term Debt | 0.07 | 0.22 | 4.59 | 5.34 | 0 | 0 | 0 |
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | - | 0.01 | 0.03 |
| Total Long-Term Liabilities | 0.07 | 0.22 | 4.59 | 5.34 | 0 | 0.01 | 0.03 |
| Total Liabilities | 4.58 | 4.18 | 10.43 | 10.71 | 4.89 | 4.08 | 2.58 |
| Total Debt | 0.16 | 0.39 | 5.03 | 5.34 | 0 | 0 | 0 |
| Debt Growth | -58.14% | -92.31% | -5.80% | - | - | - | - |
| Common Stock | 289.37 | 231.46 | 214.18 | 188.1 | 184.78 | 2.54 | 1.9 |
| Retained Earnings | -245.46 | -219.29 | -198.14 | -168.49 | -136.95 | -114.34 | -96.22 |
| Comprehensive Income | -0.01 | -0 | 0.01 | -0.01 | -0.03 | 0 | 0 |
| Shareholders' Equity | 43.9 | 12.16 | 16.05 | 19.6 | 47.8 | -111.81 | -94.32 |
| Total Liabilities and Equity | 48.48 | 16.34 | 26.47 | 30.31 | 52.69 | -107.72 | -91.74 |
| Net Cash / Debt | 45.8 | 14.01 | 13.27 | 15.38 | 50.84 | 20.8 | 3.83 |
| Net Cash / Debt Growth | 226.86% | 5.58% | -13.70% | -69.75% | 144.39% | 443.02% | - |
| Net Cash Per Share | 0.52 | 0.40 | 0.54 | 1.04 | 6.83 | 48.41 | 9.56 |
| Working Capital | 43.67 | 12.37 | 13.71 | 16.41 | 46.95 | 17 | 1.48 |
| Book Value Per Share | 0.49 | 0.35 | 0.65 | 1.33 | 6.42 | -260.20 | -235.38 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).